DIAGNOSIS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER

That this House notes the ten-fold increase over 10 years of labelling children with diagnoses of attention deficit hyperactivity disorder (ADHD); further notes the guidance by NICE on the serious potential side effects of pharmaceutical drugs prescribed for this condition; affirms that there are serious concerns about the overuse of drug treatment and notes that the UN Committee on the Rights of the Child has expressed deep concern about children being misdiagnosed with ADHD; and calls for a significant review of existing treatments and for existing studies and non-drug methods for treating children with symptoms diagnosed as ADHD to be looked into in greater depth including potential causes such as toxins in the environment, poor nutrition and other biophysical reasons.